91 related articles for article (PubMed ID: 10969402)
1. [Stabilizing the course of patients with stage IV advanced malignant melanoma by trofosfamide treatment].
Enk AH; Knop J
Hautarzt; 2000 Jul; 51(7):486-9. PubMed ID: 10969402
[TBL] [Abstract][Full Text] [Related]
2. Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis.
Reichardt P; Pink D; Tilgner J; Kretzschmar A; Thuss-Patience PC; Dörken B
Onkologie; 2002 Dec; 25(6):541-6. PubMed ID: 12566899
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
Atzpodien J; Morawek L; Fluck M; Reitz M
Cancer Chemother Pharmacol; 2009 Oct; 64(5):901-5. PubMed ID: 19229537
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
Hartmann JT; Oechsle K; Mayer F; Kanz L; Bokemeyer C
Anticancer Res; 2003; 23(2C):1899-901. PubMed ID: 12820475
[TBL] [Abstract][Full Text] [Related]
5. Partial response of metastatic mucosal melanoma after palliative chemotherapy with trofosfamide: a case report.
Aigner B; Richtig E; Becker JC; Lingitz H; Marterer R; Niederkorn A; Ugurel S
J Clin Oncol; 2013 Jan; 31(2):e31-2. PubMed ID: 23213097
[No Abstract] [Full Text] [Related]
6. Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracil.
Strumberg D; Harstrick A; Klaassen U; Müller C; Eberhardt W; Korn MW; Wilke H; Seeber S
Anticancer Drugs; 1997 Mar; 8(3):293-5. PubMed ID: 9095336
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
Reichle A; Bross K; Vogt T; Bataille F; Wild P; Berand A; Krause SW; Andreesen R
Cancer; 2004 Nov; 101(10):2247-56. PubMed ID: 15470711
[TBL] [Abstract][Full Text] [Related]
8. Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.
Witte HM; Riecke A; Mayer T; Bartscht T; Rades D; Lehnert H; Merz H; Fetscher S; Biersack H; Gebauer N
J Cancer Res Clin Oncol; 2019 Jan; 145(1):129-136. PubMed ID: 30327940
[TBL] [Abstract][Full Text] [Related]
9. Palliative chemotherapy with trofosfamide in advanced prostate cancer.
Salminen EK; Sundström J; Nikkanen V
Anticancer Res; 2006; 26(1B):539-42. PubMed ID: 16739316
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
Kollmannsberger C; Brugger W; Hartmann JT; Maurer F; Böhm P; Kanz L; Bokemeyer C
Anticancer Drugs; 1999 Jun; 10(5):453-6. PubMed ID: 10477164
[TBL] [Abstract][Full Text] [Related]
11. Palliative chemotherapy in pretreated patients with advanced cancer: oral trofosfamide is effective in ovarian carcinoma.
Gunsilius E; Gierlich T; Mross K; Gastl G; Unger C
Cancer Invest; 2001; 19(8):808-11. PubMed ID: 11768034
[TBL] [Abstract][Full Text] [Related]
12. Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature.
Jahnke K; Bechrakis NE; Coupland SE; Schmittel A; Foerster MH; Fischer L; Thiel E; Korfel A
Graefes Arch Clin Exp Ophthalmol; 2004 Sep; 242(9):771-6. PubMed ID: 15349786
[TBL] [Abstract][Full Text] [Related]
13. Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide.
Kroiss M; Deutschbein T; Schlötelburg W; Ronchi CL; Neu B; Müller HH; Quinkler M; Hahner S; Heidemeier A; Fassnacht M;
Horm Cancer; 2016 Jun; 7(3):211-8. PubMed ID: 26961793
[TBL] [Abstract][Full Text] [Related]
14. Maintenance treatment with trofosfamide in patients with primary bone ewing sarcoma - single center experience.
Raciborska A; Bilska K; Rodriguez-Galindo C
Dev Period Med; 2019; 23(1):39-44. PubMed ID: 30954980
[TBL] [Abstract][Full Text] [Related]
15. Treosulfan in the treatment of metastatic melanoma: from chemosensitivity testing to clinical trials.
Neuber K
Recent Results Cancer Res; 2003; 161():159-79. PubMed ID: 12528807
[TBL] [Abstract][Full Text] [Related]
16. [Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis].
Frick S; Lischner S; Rosien F; Haacke TC; Schäfer F; Christophers E; Hauschild A
Hautarzt; 2002 Oct; 53(10):659-65. PubMed ID: 12297947
[TBL] [Abstract][Full Text] [Related]
17. Palliative chemotherapy in non-Hodgkin's lymphoma.
Salminen E; Nikkanen V; Lindholm L
Oncology; 1997; 54(2):108-11. PubMed ID: 9075780
[TBL] [Abstract][Full Text] [Related]
18. Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.
Al-Batran SE; Atmaca A; Bert F; Jäger D; Frisch C; Neumann A; Orth J; Knuth A; Jäger E
Onkologie; 2004 Dec; 27(6):534-8. PubMed ID: 15591711
[TBL] [Abstract][Full Text] [Related]
19. Oral metronomic cyclophosphamide in elderly with metastatic melanoma.
Borne E; Desmedt E; Duhamel A; Mirabel X; Dziwniel V; Maire C; Florin V; Martinot V; Penel N; Vercambre-Darras S; Mortier L
Invest New Drugs; 2010 Oct; 28(5):684-9. PubMed ID: 19669699
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors.
Vogt T; Hafner C; Bross K; Bataille F; Jauch KW; Berand A; Landthaler M; Andreesen R; Reichle A
Cancer; 2003 Nov; 98(10):2251-6. PubMed ID: 14601096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]